ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,564.41
1.08%
Dow Jones
40,415.44
0.32%
US Dollar vs MXN
17.93835
-0.04%
Brent Oil
81.705
0.23%
Bitcoin
66,424.99
-1.74%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Healthwell Acquisition Corporation I (HWEL)

  7. Healthwell Acquisition Corporation I (HWEL) Noticias

HWEL

Healthwell Acquisition C... (HWEL)

Healthwell Acquisition Corporation I
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:HWEL
FechaHoraFuenteTítuloSímboloCompañía
17/11/202320:29Business WireHealthwell Acquisition Corp. I Announces Cancellation of Special Stockholder Meeting and its Intention to LiquidateNASDAQ:HWELHealthwell Acquisition Corporation I
03/11/202318:00Business WireHealthwell Acquisition Corp. I Announces Termination of Business Combination with Starton Therapeutics, Inc.NASDAQ:HWELHealthwell Acquisition Corporation I
23/10/202322:55Business WireHealthwell Acquisition Corp. I Announces Postponement of the Special Meeting of Stockholders to Approve the Proposed Business Combination with Starton Therapeutics, Inc. and Related TransactionsNASDAQ:HWELHealthwell Acquisition Corporation I
17/10/202305:00Business WireHealthwell Acquisition Corp. I Announces New Meeting Date for the Special Meeting of Stockholders to Approve Proposed Business Combination With Starton Therapeutics, Inc. and Related TransactionsNASDAQ:HWELHealthwell Acquisition Corporation I
04/10/202307:00Business WireStarton Therapeutics Doses First Patient in Landmark STAR-LLD Lenalidomide Phase 1b Clinical Trial in Multiple MyelomaNASDAQ:HWELHealthwell Acquisition Corporation I
13/09/202315:05Business WireStarton Therapeutics Announces the Opening of the First Clinical Site for STAR-LLD Lenalidomide Phase 1b Trial in Multiple MyelomaNASDAQ:HWELHealthwell Acquisition Corporation I
10/07/202306:00Business WireStarton Therapeutics Contracts Global Clinical Research Organization to Conduct STAR-LLD Phase 1b Clinical Trial in Multiple MyelomaNASDAQ:HWELHealthwell Acquisition Corporation I
23/06/202316:20Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:HWELHealthwell Acquisition Corporation I
13/06/202309:29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HWELHealthwell Acquisition Corporation I
13/06/202309:28Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:HWELHealthwell Acquisition Corporation I
12/06/202315:30Business WireStarton Therapeutics Receives Authorization from the FDA to Proceed with STAR-LLD Lenalidomide Phase 1b Clinical Trial in Multiple MyelomaNASDAQ:HWELHealthwell Acquisition Corporation I
07/06/202309:52Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:HWELHealthwell Acquisition Corporation I
06/06/202307:00Business WireStarton Therapeutics, Inc. and Healthwell Acquisition Corp. I to Present at the Jefferies Healthcare ConferenceNASDAQ:HWELHealthwell Acquisition Corporation I
18/05/202316:10Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:HWELHealthwell Acquisition Corporation I
15/05/202315:21Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:HWELHealthwell Acquisition Corporation I
27/04/202306:00Business WireStarton Therapeutics Inc. and Healthwell Acquisition Corp. I to Combine and Create Publicly Traded Leader in Proprietary Continuous Delivery Technology for Cancer TreatmentsNASDAQ:HWELHealthwell Acquisition Corporation I
14/02/202316:42Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:HWELHealthwell Acquisition Corporation I
10/02/202316:02Edgar (US Regulatory)

NASDAQ:HWELHealthwell Acquisition Corporation I
28/03/202216:23Edgar (US Regulatory)Annual Report (10-k)NASDAQ:HWELHealthwell Acquisition Corporation I
22/11/202105:02Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:HWELHealthwell Acquisition Corporation I
 Showing the most relevant articles for your search:NASDAQ:HWEL

Su Consulta Reciente

CCOM
SILVER
SILVER
AMEX
XLF
Financial Select Sector
USOTC
BASFY
BASF (QX)
PM
XAUUSD
Gold vs US Dollar
AMEX
SPY
SPDR S&P 500
AMEX
XLV
Health Care Select Sector
NASDAQ
GOOGL
Alphabet
AMEX
XLE
Energy Select Sector SPDR
NYSE
DIS
Walt Disney
NYSE
CVX
Chevron
COIN
ETHUSD
Ethereum
NASDAQ
AAPL
Apple
NYSE
VZ
Verizon Communications
USOTC
RHHBY
Roche (QX)
NYSE
MCD
McDonalds
FX
EURMXN
Euro vs MXN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados